Prevention of viral hepatitis in HIV co-infection

Journal of Hepatology

Volumn 44, Issue SUPPL. 1, 2006, Pages

  Brook, Gary ^a  

^a CENTRAL MIDDLESEX HOSPITAL   (United Kingdom)

Author keywords

Counselling; Hepatitis; HIV; Prevention; Vaccination

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS A VACCINE; HEPATITIS B VACCINE;

CD4 LYMPHOCYTE COUNT; CONDOM; CONFERENCE PAPER; COUNSELING; DRUG MEGADOSE; HARM REDUCTION; HEPATITIS B; HEPATITIS C; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LONG TERM CARE; PRIORITY JOURNAL; PROGNOSIS; SAFE SEX; VACCINATION; VIRUS HEPATITIS;

HEPATITIS, VIRAL, HUMAN; HIV; HIV INFECTIONS; HUMANS; PROGNOSIS; VACCINATION;

EID: 30144433845     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2005.11.022     Document Type: Conference Paper

References (35)

1. M. Bonacini, S. Louie, N. Bzowej, and A.R. Wohl Survival in patients with HIV infection and viral hepatitis B or C: a cohort study AIDS 18 2004 2039 2046
2. C. Thio, E. Seaberg, and R. Skolasky HIV-1, hepatitis B virus, and risk of liver-related mortality in the MACS Lancet 360 2002 1921 1926
3. M. Puoti, A. Spinetti, A. Ghezzi, F. Donato, S. Zaltron, and V. Putzolu Mortality for liver disease in patients with HIV infection: a cohort study J Acquir Immune Defic Syndr 24 2000 211 217
4. C. Pramoolsinsap Acute hepatitis A and immunity to hepatitits A virus in hepatitis B virus carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand J Viral Hepat 7 2000 11 12
5. E. Bianco, T. Stroffolini, E. Spada, A. Szklo, F. Marzolini, and P. Ragni Case fatality rate of acute viral hepatitis in Italy: 1995-2000. An update Dig Liver Dis 35 2003 404 408
6. C.M. Chu, C.T. Yeh, and Y.F. Liaw Fulminant hepatic failure in acute hepatitis C: increased risk in chronic carriers of hepatitis B virus Gut 45 1999 613 617
7. J.P. Zarski, B. Bohn, A. Bastie, J.M. Pawlotsky, M. Baud, and F. Bost-Bezeaux Characteristics of patients with dual infection by hepatitis B and C viruses J Hepatol 28 1998 27 33
8. M. Chiaramonte, T. Stroffolini, A. Vian, M.A. Stazi, A. Floreani, and U. Lorenzoni Rate of incidence of hepatocellular carcinoma in patients with compensated viral cirrhosis Cancer 85 1999 2132 2137
9. D.P. Francis, S.C. Hadler, S.E. Thompson, J.E. Maynard, D.G. Ostrow, and N. Altman The prevention of hepatitis B with vaccine. Report of the centers for disease control multi-center trial among homosexual men Ann Intern Med 97 1982 362 366
10. M.F. Yuen, W.L. Lim, C.C. Cheng, S.K. Lam, and C.L. Lai Twelve year follow-up of a prospective randomized trial of recombinant DNA yeast vaccine versus plasma-derived vaccine without booster doses in children Hepatology 29 1999 924 927
11. R.B. Wainwright, L.R. Bulkow, A.J. Parkinson, C. Zanis, and B.J. McMahon Protection provided by hepatitis B vaccine in a Yupik Eskimo population: results of a 10-year study J Infect Dis 175 1997 674 677
12. J.F. Modlin, D.E. Snider, R.D. Clover, D.W. Fleming, M.P. Glode, and M.R. Griffin Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) Morb Mortal Wkly Rep 48 1999 1 37
13. P. van Damme, J. Banatvala, O. Fay, S. Iwarson, B. McMahon, and K. Van Herck Hepatitis A vaccination: is there a need? Lancet 362 2003 1065 1071
14. R.H. Loke, I.M. Murray-Lyon, J.C. Coleman, B.A. Evans, and A.J. Zuckerman Diminished response to recombinant hepatitis B vaccine in homosexual men with HIV antibody: an indicator of poor response J Med Virol 31 1990 109 111
15. K.L. Wong, N.J. Bodsworth, M.A. Slade, B.P. Mulhall, and B. Donovan Response to hepatitis B vaccination in a primary care setting: influence of HIV infection, CD4+ lymphocyte count and vaccination schedule Int J STD AIDS 7 1996 490 494
16. S.C. Tayal, and K.N. Sankar Impaired response to recombinant hepatitis B vaccine in asymptomatic HIV-infected individuals AIDS 8 1994 558 559
17. D. Rey, V. Krantz, M. Partisani, M.P. Schmitt, P. Meyer, and E. Libbrecht Increasing the number of hepatitis B vaccine injections augments anti-HBs response rate in HIV-infected patients. Effects in HIV-1 viral load Vaccine 18 2000 1161 1165
18. P.M. Mannucci, A.R. Zanetti, A. Gringeri, E. Tanzi, M. Morfini, and A. Messori Long-term immunogenicity of a plasma-derived hepatitis B vaccine in HIV-seropositive and HIV-seronegative hemophiliacs Arch Intern Med 149 1989 1333 1337
19. K. Welch, and A. Morse Improving screening and vaccination for hepatitis B in patients coinfected with HIV and hepatitis C Am J Gastroenterol 97 2002 2928 2929
20. G.A. Neilsen, N.J. Bodsworth, and N. Watts Response to hepatitis A vaccine in immunodeficiency-virus-infected and -uninfected homosexual men J Infect Dis 176 1997 1064 1067
21. M. Sasaki, R. Foccacia, and R.I.J. de-Messias Efficacy of granulocyte-macrophage-colony-stimulating factor (GM-CSF) as a vaccine adjuvant for hepatitis B virus in patients with HIV infection Vaccine 21 2003 4545 4549
22. H. Valdez, R. Mitsuyasu, A. Landay, A.D. Sevin, E.S. Chan, and J. Spritzler Interleukin-2 increases CD4+ lymphocyte numbers but does not enhance response to immunization: results of A5046s J Infect Dis 187 2003 320 325
23. D. Kapoor, S.R. Aggarwal, N.P. Singh, V. Thakur, and S.K. Sarin Granulocyte-macrophage-colony-stimulating factor enhances the efficacy of hepatitis B virus vaccine in previously unvaccinated haemodialysis patients J Viral Hepat 6 1999 405 409
24. J. Sanchez, E. Gotuzzo, J. Escamilla, C. Carrillo, L. Moreyra, and W. Stamm Sexually transmitted infections in female sex workers: reduced by condom use but not by a limited periodic examination programme Sex Transm Dis 25 1998 82 89
25. G. Bhave, C.P. Lindan, E.S. Hudes, S. Desai, U. Wagle, and S.P. Tripathi Impact of an intervention on HIV, sexually transmitted diseases and condom use among sex workers in Bombay AIDS 9 1995 S21 S30
26. M. Tanaka, H. Nakayama, M. Sakumoto, T. Matsumoto, K. Akazawa, and J. Kumazawa Trends in sexually transmitted diseases and condom use patterns among commercial sex workers in Fukuoka City, Japan 1990-93 Genitourin Med 72 1996 358 361
27. T. Stewart, and N. Crofts An outbreak of hepatitis A among homosexual men in Melbourne Med J Aust 158 1993 519 521
28. R. Reintjes, A. Bosman, O. de Zwart, M. Stevens, L. van der Knaap, and K. van den Hoek Outbreak of hepatitis A in Rotterdam associated with visits to 'darkrooms' in gay bars Commun Dis Public Health 2 1999 43 46
29. A. Bell, F. Ncube, A. Hansell, K.L. Davison, Y. Young, and R. Gilson An outbreak of hepatitis A among young men associated with having sex in public venues Commun Dis Public Health 4 2001 163 170
30. A.S. Mansson, T. Moestrup, E. Nordenfelt, and A. Widell Continued transmission of hepatitis B and C viruses, but no transmission of human immunodeficiency virus amongst inatravenous drug users participating in a syringe/needle exchange program Scand J Infect Dis 32 2000 253 258
31. E.J. Amundsen, E. Eskild, H. Stigum, E. Smith, and O.O. Aalen Legal access to needles and syringes/needle exchange programmes versus HIV counselling and testing to prevent transmission of HIV among intravenous drug users Eur J Public Health 13 2003 252 258
32. K.H. Seal, A.H. Kral, J. Lorvick, A. McNees, L. Gee, and B.R. Edlin A randomized controlled trail of monetary incentives vs outreach to enhance the adherence to the hepatitis B vaccine series among injection drug users Drug Alcohol Depend 71 2003 127 131
33. L. Borg, E. Khuri, A. Wells, D. Melia, N.V. Bergasa, and A. Ho Methadone-maintained former heroine addicts, including those who are anti-HIV-1 seropositive, comply with and respond to hepatitis B vaccination Addiction 94 1999 489 493
34. J.N. Zuckerman, and A.J. Zuckerman Recombinant hepatitis B triple antigen vaccine: hepacare Expert Rev Vaccines 1 2002 141 144
35. A. Fomsgaard, A.V. Nielsen, C. Nielsen, K. Johansson, R. Machuca, and L. Bruun Comparisons of DNA-mediated immunization procedures directed against surface glycoproteins of human immunodeficiency virus type 1 and hepatitis B virus Acta Pathol Microbiol Immunol Scand 106 1998 636 646